Targeting cancer-associated glycans as a therapeutic strategy in leukemia
Unlike cytotoxic chemotherapy, cancer immunotherapy offers targeted therapies that exploit the effector mechanisms of the immune system to combat cancer. However, most therapeutic strategies have so far focused predominantly on the orchestration of the adaptive immune responses to anti-cancer immuno...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | All Life |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/26895293.2022.2049901 |